| CTRI Number |
CTRI/2024/08/073018 [Registered on: 28/08/2024] Trial Registered Prospectively |
| Last Modified On: |
27/08/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Diagnostic Preventive |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Effect of Phaltrikadi Kwatha and Vasadi Kashaya in Jaundice |
|
Scientific Title of Study
|
A comparative clinical study to evaluate the efficacy of Phalatrikadi Kwatha and Vasadi Kashaya in management of Bahupitta Kamala |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Shruti Suryakant Shelke |
| Designation |
PG Scholar Kayachikitsa |
| Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune |
| Address |
O.P.D. NO 2 Kayachikitsa Department Ground Floor Saneguruji Arogya Kendra Malwadi Hadapsar Pune
Pune MAHARASHTRA 411028 India |
| Phone |
7741975329 |
| Fax |
|
| Email |
shrutishelke007@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sachinkumar Patil |
| Designation |
Head of Department ,Department of Kayachikitsa |
| Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune |
| Address |
O.P.D. NO 2 Kayachikitsa Department Ground Floor Saneguruji Arogya Kendra Malwadi Hadapsar Pune
Pune MAHARASHTRA 411028 India |
| Phone |
9822603608 |
| Fax |
|
| Email |
drsachinkumarpatil@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Shruti Suryakant Shelke |
| Designation |
PG Scholar Kayachikitsa |
| Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune |
| Address |
O.P.D. NO 2 Kayachikitsa Department Ground Floor Saneguruji Arogya Kendra Malwadi Hadapsar Pune
Pune MAHARASHTRA 411028 India |
| Phone |
7741975329 |
| Fax |
|
| Email |
shrutishelke007@gmail.com |
|
|
Source of Monetary or Material Support
|
| MAMS Sumatibhai Shah Ayurved College O.P.D.NO 2 Kayachikitsa Department Ground Floor Sane guruji Arogya Kendra Hadapsar Pune-411028 maharashtra India |
|
|
Primary Sponsor
|
| Name |
Dr Shruti Suryakant Shelke |
| Address |
O.P.D.NO 2 Kayachikitsa Department Ground Floor Sane Guruji Arogya Kendra Malwadi Hadapsar Pune-411028 Maharashtra India |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shruti Suryakant Shelke |
Saneguruji Arogya Kendra Malwadi Hadapsar Pune 411028 |
O.P.D.NO 2 Kayachikitsa Department ground floor Sane Guruji Arogya Kendra malwadi hadapsar Pune Pune MAHARASHTRA |
7741975329
shrutishelke007@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee MAMS Sumatibhai Shah Ayurved Mahavidyalaya And Sane Guruji Arogya Kendra |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K768||Other specified diseases of liver. Ayurveda Condition: KAMALA, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Phaltrikadi Kwatha, Reference: Bhaishajya Ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: (2) Medicine Name: Phaltrikadi Kwatha, Reference: Bhaishajya Ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Vasadi Kashaya, Reference: Bhaishajya Ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: (2) Medicine Name: Vasadi Kashaya, Reference: Bhaishajya Ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1.
Age limit is from 18 to 60 years irrespective of Gender, Occupation, Religion and Economical condition.
2.
Patients having raised serum bilirubin 1.5-15 mg/dl
3.
Having signs and symptoms of Bahupitta Kamala
1.Haridra Netra
2.Rakta peet mutrata
3..Daha
4.Haridra Twak
5.Avipaka
6.Dourbalya
7.Aruchi
8.Anutsaha |
|
| ExclusionCriteria |
| Details |
1.
Known cases of HIV infection, Malignancy
2.
Patients in hepatic encephalopathy.
3.
Serum bilirubin more than 15 mg/dl
4.
Pregnant & lactating mother
5.
Psychotic patients
6.
Congenital Causes -Gilbert’s Syndrome
7.
Drug induced hyper bilirubinaemia, Liver abscess |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Alternation |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
LFTs
To compare the efficacy of Phalatrikadi Kwatha and Vasadi Kashaya in Bahupitta Kamala |
At base line ,15th day ,30th day,45th day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To Observe adverse effects of Phalatrikadi Kwatha and Vasadi Kashaya |
At base line ,15th day ,30th day,45th day |
|
|
Target Sample Size
|
Total Sample Size="66" Sample Size from India="66"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
08/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Infections, drugs, alcohol and other dietary and environmental toxins induce structural and functional damage and predispose the liver to vast array of disorders. Bahupitta Kamala. i.e. Hyperbilirubinemia is a very common disorder found now a days. In this disease aversion to all desires i.e. food ,exercise ,work, etc. occurs . Bahupitta Kamala is a disease of Raktavaha strotasa, which is given in Ayurvedic texts. In Bahupitta Kamala, the Pitta Dosha of body increases due to Ushna and Tiksna Guna of Pitta. Kamala is mentioned in Ayurvedic texts can be compared with Jaundice Jaundice is a medical condition characterized by the yellowing of the skin and eyes due to elevated levels of bilirubin in the bloodstream. It can be caused by various factors such as liver disease, hepatitis, alcohol abuse, certain medications, or other underlying health conditions. While conventional medical treatments for jaundice primarily focus on addressing the underlying cause and providing supportive care, traditional systems of medicine, such as Ayurveda, have been explored for their potential efficacy in managing the condition. The key ingredients in Phalatrikadi Kwatha and Vasadi Kashaya are believed to possess hepatoprotective, antioxidant, anti-inflammatory, and immunomodulatory properties, which could potentially aid in the treatment of jaundice. While Phalatrikadi Kwatha and Vasadi Kashaya shows promise in traditional use and some preclinical studies, it is essential to note that scientific evidence regarding its efficacy in jaundice is limited. Most of the available studies are preclinical or based on traditional knowledge, and clinical trials are required to establish its effectiveness and safety in the management of jaundice conducting a comparative study of the efficacy of Phalatrikadi Kwatha and Vasadi Kashaya in Bahupitta Kamala is important to provide scientific evidence, evaluate safety, and support their integration into evidence-based healthcare practices. This research can contribute to the overall understanding and utilization of Ayurvedic formulations for liver disorders, benefiting patients and healthcare providers alike. Hence Selected this topic for Study |